ETON logo

Eton Pharmaceuticals, Inc.

ETON
Healthcare|Drug Manufacturers - Specialty & Generic|US
$56.46
+9.31 (+19.75%)
Tangible Book / Share
$1.49
Graham Number
$10.90
Cash / Share
$1.94
Next Earnings Report
Mar 18, 2027
EPS est. $0.38 · Revenue est. $45.9M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results
Nov 5, 2026 · GlobeNewsWire
Eton Pharmaceuticals Announces Preliminary ET-700 Pilot Study Results Evaluating Copper Absorption Inhibition and Gastrointestinal Tolerability
Nov 5, 2026 · GlobeNewsWire
Eton Pharmaceuticals to Present at 2026 Jefferies Global Healthcare Conference in London
Nov 4, 2026 · GlobeNewsWire
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 3, 2026 · GlobeNewsWire
Eton Pharmaceuticals Announces Licensing and Initiation of ET-900 Program Evaluating Mecasermin/IGF-1 for Treatment of Infantile and Epileptic Spasms
Nov 2, 2026 · GlobeNewsWire
Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Oct 29, 2026 · GlobeNewsWire
Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film
Oct 14, 2026 · GlobeNewsWire
Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules
Sep 28, 2026 · GlobeNewsWire
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
Aug 27, 2026 · GlobeNewsWire
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
Aug 13, 2026 · GlobeNewsWire

SEC Filings (68)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 2, 20268-KMaterial eventDocumentIndex
Oct 14, 20268-KMaterial eventDocumentIndex
Sep 28, 20268-KMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 20268-KMaterial eventDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Aug 4, 20268-KMaterial eventDocumentIndex
Jul 29, 20268-KMaterial eventDocumentIndex
Jul 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jun 9, 20268-KMaterial eventDocumentIndex
May 19, 20268-KMaterial eventDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
May 1, 20268-KMaterial eventDocumentIndex
Apr 27, 20268-KMaterial eventDocumentIndex
Apr 24, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 16, 20268-KMaterial eventDocumentIndex
Apr 15, 20268-KMaterial eventDocumentIndex
Mar 26, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Mar 19, 202610-KAnnual reportDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Mar 6, 2026S-8Employee stock planDocumentIndex
Mar 2, 20268-KMaterial eventDocumentIndex
Feb 25, 20268-KMaterial eventDocumentIndex
Feb 2, 20268-KMaterial eventDocumentIndex
Dec 4, 20258-KMaterial eventDocumentIndex
Nov 19, 2025S-8Employee stock planDocumentIndex
Nov 18, 20258-K/AMaterial eventDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 30, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 7, 202510-QQuarterly reportDocumentIndex
Aug 7, 20258-KMaterial eventDocumentIndex
Jul 17, 2025SC 13GPassive 5%+ stakeDocumentIndex
Jul 8, 20258-KMaterial eventDocumentIndex
Jun 27, 20258-KMaterial eventDocumentIndex